General information about company
Scrip code*		544339
NSE Symbol*		LAXMIDENTL
MSEI Symbol*		NOTLISTED
ISIN*		INE0WO601020
Name of company		Laxmi Dental Limited
Type of company		Main Board
Class of security		Equity
Date of start of financial year		01-04-2025
Date of end of financial year		31-03-2026
Date of board meeting when results were approved		11-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange		05-11-2025
Description of presentation currency		INR
Level of rounding		Millions
Reporting Type		Quarterly
Reporting Quarter		Second quarter
Nature of report standalone or consolidated		Standalone
Whether results are audited or unaudited for the quarter ended		Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended		Unaudited
Segment Reporting		Single segment
Description of single segment		Integrated Dental Products
Start date and time of board meeting		11-11-2025 16:00
End date and time of board meeting		11-11-2025 17:30
Whether cash flow statement is applicable on company		Yes
Type of cash flow statement		Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification		Declaration of unmodified opinion
Whether the company has any related party?		Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?		Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public		NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.		NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?		No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?		Yes
Latest Date on which RPT policy is updated		13-02-2025
Indicate Company website link for updated RPT policy of the Company		https://www.laxmidentallimited.com/corporate_governance/policies
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?		Yes
No. of times funds raised during the quarter		1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?		Yes

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-07-2025	01-04-2025
Date of end of reporting period		30-09-2025	30-09-2025
Whether results are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	542.57	1043.7
	Other income	23.69	40.3
	Total income	566.26	1084
2	Expenses
(a)	Cost of materials consumed	125.63	206.27
(b)	Purchases of stock-in-trade	71.96	122.91
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-5.78	16.92
(d)	Employee benefit expense	194.78	369.32
(e)	Finance costs	1.35	2.76
(f)	Depreciation, depletion and amortisation expense	26.39	51.22
(g)	Other Expenses
1	Other Expenses	79.18	151.89
	Total other expenses	79.18	151.89
	Total expenses	493.51	921.29
3	Total profit before exceptional items and tax	72.75	162.71
4	Exceptional items	0	0
5	Total profit before tax	72.75	162.71
6	Tax expense
7	Current tax	21.29	40.8
8	Deferred tax	-4.14	-2.06
9	Total tax expenses	17.15	38.74
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	55.6	123.97
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	10.1	20.32
16	Total profit (loss) for period	65.7	144.29
17	Other comprehensive income net of taxes	-1.37	-2.74
18	Total Comprehensive Income for the period	64.33	141.55
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	109.92	109.92
	Face value of equity share capital	2	2
22	Reserves excluding revaluation reserve
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	1.2	2.63
	Diluted earnings (loss) per share from continuing operations	1.19	2.61
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
iii	Earnings per equity share (for continuing and discontinued operations)
	Basic earnings (loss) per share from continuing and discontinued operations	1.2	2.63
	Diluted earnings (loss) per share from continuing and discontinued operations	1.19	2.61
24	Debt equity ratio			Textual Information( 1)
25	Debt service coverage ratio			Textual Information( 2)
26	Interest service coverage ratio			Textual Information( 3)
27	Disclosure of notes on financial results	Textual Information(4)

Statement of Asset and Liabilities
Particulars		Half Year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2025
Date of end of reporting period		30-09-2025
Whether results are audited or unaudited		Unaudited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	387.66
	Capital work-in-progress	17.11
	Investment property	0.34
	Goodwill	0
	Other intangible assets	16.41
	Intangible assets under development	0
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	685.15
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	408.47
	Total non-current financial assets	408.47
	Deferred tax assets (net)	59.22
	Other non-current assets	0
	Total non-current assets	1574.36
2	Current assets
	Inventories	170.45
	Current financial asset
	Current investments	0
	Trade receivables, current	294.63
	Cash and cash equivalents	51.17
	Bank balance other than cash and cash equivalents	127.58
	Loans, current	5.88
	Other current financial assets	267.12
	Total current financial assets	746.38
	Current tax assets (net)	19.09
	Other current assets	173.66
	Total current assets	1109.58
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	2683.94
	Total current assets	1109.58
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	2683.94
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	109.92
	Other equity	2292.28
	Total equity attributable to owners of parent	2402.2
	Non controlling interest
	Total equity	2402.2
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade Payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	5.7
	Total non-current financial liabilities	5.7
	Provisions, non-current	37.65
	Deferred tax liabilities (net)	0
	Deferred government grants, Non-current	0
	Other non-current liabilities	37.79
	Total non-current liabilities	81.14
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade Payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	14.41
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	50.19
	Total Trade payable	64.6
	Other current financial liabilities	71.64
	Total current financial liabilities	136.24
	Other current liabilities	54.91
	Provisions, current	9.45
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	200.6
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	281.74
	Total equity and liabilities	2683.94
	Disclosure of notes on assets and liabilities	Textual Information(1)

Other Comprehensive Income
Date of start of reporting period		01-07-2025	01-04-2025
Date of end of reporting period		30-09-2025	30-09-2025
Whether results are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurement gain/(loss) of net defined benefit plan	-1.83	-3.66
	Total Amount of items that will not be reclassified to profit and loss	-1.83	-3.66
2	Income tax relating to items that will not be reclassified to profit or loss	-0.46	-0.92
3	Amount of items that will be reclassified to profit and loss
1	Foreign Currency Translation Reserve	0.00	0.00
	Total Amount of items that will be reclassified to profit and loss	0.00	0.00
4	Income tax relating to items that will be reclassified to profit or loss	0.00	0.00
5	Total Other comprehensive income	-1.37	-2.74

Cash flow statement, indirect
Particulars		Half Year ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2025
Date of end of reporting period		30-09-2025
Whether results are audited or unaudited		Unaudited
Nature of report standalone or consolidated		Standalone
Part I	Blue color marked fields are non-mandatory.
1	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax	162.71
2	Adjustments for reconcile profit (loss)
	Adjustments for finance costs	0
	Adjustments for decrease (increase) in inventories	-3.73
	Adjustments for decrease (increase) in trade receivables, current	-35.35
	Adjustments for decrease (increase) in trade receivables, non-current	0
	Adjustments for decrease (increase) in other current assets	0
	Adjustments for decrease (increase) in other non-current assets	-61.8699706092228
	Adjustments for other financial assets, non-current	-107.2
	Adjustments for other financial assets, current	0
	Adjustments for other bank balances	0
	Adjustments for increase (decrease) in trade payables, current	-228.35
	Adjustments for increase (decrease) in trade payables, non-current	0
	Adjustments for increase (decrease) in other current liabilities	0
	Adjustments for increase (decrease) in other non-current liabilities	-5.86
	Adjustments for depreciation and amortisation expense	51.22
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss	-5.25
	Adjustments for provisions, current	0
	Adjustments for provisions, non-current	0
	Adjustments for other financial liabilities, current	0
	Adjustments for other financial liabilities, non-current	20.13
	Adjustments for unrealised foreign exchange losses gains	-7.65
	Adjustments for dividend income	0
	Adjustments for interest income	22.93
	Adjustments for share-based payments	18.16
	Adjustments for fair value losses (gains)	-0.15
	Adjustments for undistributed profits of associates	0
	Other adjustments for which cash effects are investing or financing cash flow	0
	Other adjustments to reconcile profit (loss)	0
	Other adjustments for non-cash items	0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships	20.32
	Total adjustments for reconcile profit (loss)	-368.51
	Net cash flows from (used in) operations	-205.8
	Dividends received	0
	Interest paid	2.76
	Interest received	0
	Income taxes paid (refund)	-35.56
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) operating activities	-173
3	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses	0
	Cash flows used in obtaining control of subsidiaries or other businesses	0
	Other cash receipts from sales of equity or debt instruments of other entities	0
	Other cash payments to acquire equity or debt instruments of other entities	0
	Other cash receipts from sales of interests in joint ventures	0
	Other cash payments to acquire interests in joint ventures	0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships	0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships	514.86
	Proceeds from sales of property, plant and equipment	0
	Purchase of property, plant and equipment	56.53
	Proceeds from sales of investment property	0
	Purchase of investment property	0
	Proceeds from sales of intangible assets	0
	Purchase of intangible assets	3.6
	Proceeds from sales of intangible assets under development	0
	Purchase of intangible assets under development	0
	Proceeds from sales of goodwill	0
	Purchase of goodwill	0
	Proceeds from biological assets other than bearer plants	0
	Purchase of biological assets other than bearer plants	0
	Proceeds from government grants	0
	Proceeds from sales of other long-term assets	0
	Purchase of other long-term assets	0
	Cash advances and loans made to other parties	0
	Cash receipts from repayment of advances and loans made to other parties	0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts	0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts	0
	Dividends received	0
	Interest received	22.28
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	-91.63
	Net cash flows from (used in) investing activities	-644.34
4	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries	0
	Payments from changes in ownership interests in subsidiaries	0
	Proceeds from issuing shares	0
	Proceeds from issuing other equity instruments	0
	Payments to acquire or redeem entity's shares	0
	Payments of other equity instruments	0
	Proceeds from exercise of stock options	0
	Proceeds from issuing debentures notes bonds etc	0
	Proceeds from borrowings	0
	Repayments of borrowings	0
	Payments of lease liabilities	16.33
	Dividends paid	0
	Interest paid	0
	Income taxes paid (refund)	0
	Other inflows (outflows) of cash	0
	Net cash flows from (used in) financing activities	-16.33
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes	-833.67
5	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents	0
	Net increase (decrease) in cash and cash equivalents	-833.67
	Cash and cash equivalents cash flow statement at beginning of period	884.84
	Cash and cash equivalents cash flow statement at end of period	51.17

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.

Sr. No.

Details of the party (listed entity /subsidiary) entering into the transaction

Details of the counterparty

Type of related party transaction

Details of other related party transaction

Value of the related party transaction as approved by the audit committee

Remarks on approval by audit committee

Value of the related party transaction ratified by the audit committee

Date of Audit Committee Meeting where the ratification was approved

Value of transaction during the reporting period

In case monies are due to either party as a result of the transaction

In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments

Details of the loans, inter-corporate deposits, advances or investments

Name

PAN

Name

PAN

Relationship of the counterparty with the listed entity or its subsidiary

Opening balance

Closing balance

Nature of indebtedness (loan/ issuance of debt/ any other etc.)

Details of other indebtedness

Cost

Tenure

Nature (loan/ advance/ intercorporate deposit/ investment)

Interest Rate (%)

Tenure

Secured/ unsecured

Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)

Notes

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Mr. Rajesh Khakhar

AEHPK4847J

Whole time Director & Chairman

Remuneration

4.5

Approved

4.5

0.7

0.8

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Mr. Sameer Merchant

AHZPM1271H

CEO and Managing Director

Remuneration

4.5

Approved

4.5

0.7

0.8

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Mr. Dharmesh Dattani

AEGPD0657L

Chief Finance Officer

Remuneration

Approved

0.45

0.55

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Mr. Parth Khakhar

CPEPK1442P

Relative of Director and KMP

Remuneration

4.67

Approved

4.67

0.75

0.78

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Mrs. Jigna R Khakhar

AHQPK9538E

Relative of Director and KMP

Remuneration

0.4

Approved

0.4

0.2

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Mr. Manan Khakhar

EBSPK1418R

Relative of Director and KMP

Remuneration

2.4

Approved

2.4

0.3

0.4

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

MR. Hasmukh Khakhar

AGJPK5735B

Relative of Director and KMP

Remuneration

0.3

Approved

0.3

0.15

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Mr. Shubh Sanjay Khakhar

LJGPK2587J

Relative of Director and KMP

Remuneration

1.37

Approved

1.37

0.21

0.25

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Ms. Siddhi Khakhar

GARPK8883C

Relative of Director and KMP

Remuneration

0.6

Approved

0.6

0.25

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Mr. Rajesh Khakhar

AEHPK4847J

Whole time Director & Chairman

Any other transaction

Rent Paid

0.36

Approved

0.36

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Laxmi Dental Lab USA INC

ZZZZZ9999Z

Subsidiary

Purchase of goods or services

8.01

Approved

8.01

0.26

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Bizdent Devices Private Limited

AAJCB7470K

Subsidiary

Purchase of goods or services

2.48

Approved

2.48

0.01

0.31

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Rich Smile Design LLP

AUJPJ1353J

Subsidiary

Purchase of goods or services

0.12

Approved

0.12

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Laxmi Dental Lab USA INC

ZZZZZ9999Z

Subsidiary

Sale of goods or services

116.56

Approved

116.56

79.63

0.36

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Signature Smiles Dental Clinic Private Limited

AAOCS9802K

Subsidiary

Sale of goods or services

3.52

Approved

3.52

0.62

2.26

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Bizdent Devices Private Limited

AAJCB7470K

Subsidiary

Sale of goods or services

19.08

Approved

19.08

12.29

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Rich Smile Design LLP

AUJPJ1353J

Subsidiary

Sale of goods or services

0.66

Approved

0.66

0.2

0.08

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Kids E Dental LLP

AASFK3032C

Jointly controlled Entity

Sale of goods or services

2.96

Approved

2.96

0.1

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Laxmi Dental Lab USA INC

ZZZZZ9999Z

Subsidiary

Any other transaction

Other Income

8.86

Approved

8.86

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Signature Smiles Dental Clinic Private Limited

AAOCS9802K

Subsidiary

Interest received

0.26

Approved

0.26

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Kids E Dental LLP

AASFK3032C

Jointly controlled Entity

Any other transaction

Rent Received

0.29

Approved

0.29

0.1

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Kids E Dental LLP

AASFK3032C

Jointly controlled Entity

Any other transaction

Share of Profit

20.32

Approved

20.32

102.23

122.55

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Signature Smiles Dental Clinic Private Limited

AAOCS9802K

Subsidiary

Loan

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Laxmi Dental Lab USA INC

ZZZZZ9999Z

Subsidiary

Investment

85.7

Approved

85.7

64.82

150.52

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Signature Smiles Dental Clinic Private Limited

AAOCS9802K

Subsidiary

Investment

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Bizdent Devices Private Limited

AAJCB7470K

Subsidiary

Investment

409.15

Approved

409.15

35.1

444.25

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Rich Smile Design LLP

AUJPJ1353J

Subsidiary

Investment

0.07

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

Kids E Dental LLP

AASFK3032C

Jointly controlled Entity

Investment

0.3

Laxmi Dental Limited (Formerly known as Laxmi Dental Export Private Limited)

AABCL0001A

IDBG AI Dent Global Private limited

AAHCI9496E

Associate

Investment

20.01

Approved

20.01

Total value of transaction during the reporting period

720.08

Details of Impact of Audit Qualification
Whether results are audited or unaudited		Unaudited
Declaration of unmodified opinion or statement on impact of audit qualification		Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results		No
	Audit firm's name	Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI	Certificate valid upto
1	M S K A & Associates	Yes	31-07-2027

Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Mode of Fund Raising	Public Issues
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds	16-01-2025
Amount Raised	6980.58
Report filed for Quarter ended	30-09-2025
Monitoring Agency	Applicable
Monitoring Agency Name, if applicable	ICRA Limited
Is there a Deviation / Variation in use of funds raised	No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation
Comments of the Audit Committee after review
Comments of the auditors, if any

Sr.	Original Object	Modified Object, if any	Original Allocation	Modified allocation, if any	Funds Utilised	Amount of Deviation/Variation for the quarter according to applicable object	Remarks if any
1	Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by our Company	NA	229.84	0	229.84	0
2	Investment in certain Subsidiaries for the repayment/prepayment, in full or in part, of certain outstanding borrowings.	NA	46	0	46	0
3	Funding the capital expenditure requirements for purchase of new machinery for our Company.	NA	435.07	0	45.98	0
4	Investment in our Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery.	NA	250.04	0	0	0
5	General corporate purposes.	NA	320.75	0	319.36	0

Signatory Details
Name of signatory	Sameer Kamlesh Merchant
Designation of person	Managing Director
Place	Mumbai
Date	11-11-2025

Format for Disclosing Outstanding Default on Loans and Debt Securities
Sr. No.	Particulars	Amount	Remarks
1.	Loans / revolving facilities like cash credit from banks / financial institutions
A	Total amount outstanding as on date	0
B	Of the total amount outstanding, amount of default as on date	0
2.	Unlisted debt securities i.e. NCDs and NCRPS
A	Total amount outstanding as on date	0
B	Of the total amount outstanding, amount of default as on date	0
3.	Total financial indebtedness of the listed entity including short-term and long-term debt	0

General information about company

Financial Results – Ind-AS

Statement of Asset and Liabilities

Other Comprehensive Income

Cash flow statement, indirect

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Details of Impact of Audit Qualification

Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Signatory Details

Format for Disclosing Outstanding Default on Loans and Debt Securities